The Genomic Medicine Model aims to facilitate patient engagement, patient/provider education of genomics/personalized medicine, and uptake of risk-stratified evidence-based prevention guidelines using MeTree, a patient-facing family health history (FHH) collection and clinical decision support (CDS) program. Here we report the number of increased risk (above population-level risk) patients identified for breast/ovarian cancer, colon cancer, hereditary syndrome risk, and thrombosis; the prevalence of FHH elements triggering increased-risk status; and the resources needed to manage their risk. Study design: hybrid implementation-effectiveness study of adults with upcoming well-visits in 2 primary care practices in Greensboro, NC. Participants...
This systematic review evaluated the effectiveness of strategies to identify and manage patients wit...
BACKGROUND: Primary care is expected to play a significant role in the management of patients with g...
Genomic medicine is expanding from a focus on diagnosis at the patient level to prevention at the po...
As an essential tool for risk stratification, family health history (FHH) is a central component of ...
Background: Family health history (FHH) is an underutilized tool in primary care to identify and ris...
Primary care providers (PCPs) offered input regarding the incorporation of a family health history (...
Introduction: Family health history is a strong predictor of disease risk. To reduce the morbidity a...
Family history of breast cancer is a key risk factor, accounting for up to 10% of cancers. We evalua...
Background: The CDC's Family History Public Health Initiative encourages adoption and increase aware...
Background: Studies have shown that the quality of family health history (FHH) collection in primary...
Published onlineJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tBACKGROUND...
Family health history (FHH) is a valuable yet underused healthcare tool for assessing health risks f...
Background: Primary care is expected to play a significant role in the management of patients with g...
Evidence indicates that many barriers exist to the integration of genetic case finding into primary ...
Breast cancer is the second leading cause of cancer death and the leading cause of premature death o...
This systematic review evaluated the effectiveness of strategies to identify and manage patients wit...
BACKGROUND: Primary care is expected to play a significant role in the management of patients with g...
Genomic medicine is expanding from a focus on diagnosis at the patient level to prevention at the po...
As an essential tool for risk stratification, family health history (FHH) is a central component of ...
Background: Family health history (FHH) is an underutilized tool in primary care to identify and ris...
Primary care providers (PCPs) offered input regarding the incorporation of a family health history (...
Introduction: Family health history is a strong predictor of disease risk. To reduce the morbidity a...
Family history of breast cancer is a key risk factor, accounting for up to 10% of cancers. We evalua...
Background: The CDC's Family History Public Health Initiative encourages adoption and increase aware...
Background: Studies have shown that the quality of family health history (FHH) collection in primary...
Published onlineJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tBACKGROUND...
Family health history (FHH) is a valuable yet underused healthcare tool for assessing health risks f...
Background: Primary care is expected to play a significant role in the management of patients with g...
Evidence indicates that many barriers exist to the integration of genetic case finding into primary ...
Breast cancer is the second leading cause of cancer death and the leading cause of premature death o...
This systematic review evaluated the effectiveness of strategies to identify and manage patients wit...
BACKGROUND: Primary care is expected to play a significant role in the management of patients with g...
Genomic medicine is expanding from a focus on diagnosis at the patient level to prevention at the po...